TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/05/2024
Voltar para busca
Dado oficial do USPTO
LYSEBLUE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
03/05/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
16/11/2005
Data de registro
02/10/2007
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/09/2017
Última transação
03/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Hilden, DE
Examinador
GRIFFIN, JAMES
Unidade examinadora
L30
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
QIAGEN GmbH
QIAGEN GmbH
Representantes
Victoria Friedman Dennemeyer & Associates, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemical and biotechnological products for industrial and scientific purposessolutions for protein processingbuffersreagentsindicatorslysis compositionswash compositionsbinding compositionsenzymessolvents for the preparation of samplesthe modification and manipulation of cells as well as performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; diagnostic preparationsexcept for human medical and veterinary medical purposes; reagents and solventsnot for medical or veterinary purposesin particular for the preparation of samplesthe modification and manipulation of cells as well as for performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; kits comprising products for scientific and research diagnostic purposescomposed of solutions for protein processingbuffersreagentsindicatorslysis compositionswash compositionsbinding compositionsenzymessolventsin particular for the preparation of samplesthe modification and manipulation of cells as well as for the markingseparationisolationpurificationreproduction and analysis of biopolymersin particular nucleic acidsproteinsmacromoleculesbiologically active substances in particular nucleic acids from biological and biochemical sample material
Classe 5
Products for medical and veterinary medical purposesin particular diagnostic preparationsin particular for the preparation of samplesthe modification and manipulation of cells and for the markingseparationisolationpurification and reproduction and the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; chemicalbiochemical and biotechnological productsin particular reagents and solvents for medical and veterinary use for the preparation of samplesthe modification and the manipulation of cells as well as for performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; kits comprising products for medical and veterinary medical diagnostic purposes composed of solutions for protein processingbuffersreagentsindicatorslysis compositionswash compositionsbinding compositionsenzymessolventsbinding supportsin particular for the preparation of samplesthe modification and manipulation of cells and for markingseparationisolationpurificationreproduction and analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample material
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/07/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
21/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/07/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
13/09/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
13/09/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13/09/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
11/09/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/10/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/10/2013
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/10/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/10/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
01/10/2013
E815
TEAS SECTION 8 & 15 RECEIVED
01/10/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2007
PUBO
PUBLISHED FOR OPPOSITION
17/07/2007
NPUB
NOTICE OF PUBLICATION
27/06/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/05/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/05/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2007
ALIE
ASSIGNED TO LIE
02/05/2007
PAPER RECEIVED
03/04/2007
GNSL
LETTER OF SUSPENSION E-MAILED
11/01/2007
CNSL
SUSPENSION LETTER WRITTEN
11/01/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
27/12/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/11/2006
PAPER RECEIVED
24/11/2006
GNRT
NON-FINAL ACTION E-MAILED
23/05/2006
CNRT
NON-FINAL ACTION WRITTEN
23/05/2006
DOCK
ASSIGNED TO EXAMINER
16/05/2006
NWAP
NEW APPLICATION ENTERED
22/11/2005
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LYSEBLUE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.